Alaunos Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 22.56 K | $64.53 K | 14.31% | 1.16% |
| BLACKROCK, INC. | 05/13/2026 | 21.35 K | $61.07 K | 0.00% | 1.10% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 15.50 K | $44.32 K | 100.00% | 0.80% |
| 05/15/2026 | 14.06 K | $40.22 K | 100.00% | 0.72% | |
| HRT FINANCIAL LP | 05/14/2026 | 13.33 K | $38.00 K | 5.75% | 0.68% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 10.84 K | $31.00 K | -41.69% | 0.56% |
| CITADEL ADVISORS LLC | 05/15/2026 | 10.52 K | $30.08 K | 100.00% | 0.54% |
| XTX TOPCO LTD | 05/15/2026 | 10.17 K | $29.10 K | 100.00% | 0.52% |
| UBS GROUP AG | 05/05/2026 | 2.27 K | $6.50 K | 73.72% | 0.12% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 1.78 K | $5.08 K | 65.33% | 0.09% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 1.58 K | $4.53 K | 46.44% | 0.08% |
| MORGAN STANLEY | 05/15/2026 | 653 | $1.87 K | -60.35% | 0.03% |
| VANGUARD GLOBAL ADVISERS, LLC | 05/08/2026 | 501 | $1.43 K | 100.00% | 0.03% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 190 | $543 | 6.74% | 0.01% |
| ROYAL BANK OF CANADA | 05/15/2026 | 185 | $1.00 K | 100.00% | 0.01% |
| RONALD BLUE TRUST, INC. | 04/20/2026 | 135 | $386 | 0.00% | 0.01% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 05/08/2026 | 92 | $263 | 0.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 05/14/2026 | 70 | $200 | 0.00% | 0.00% |
| KEY FINANCIAL INC | 04/24/2026 | 24 | $69 | 0.00% | 0.00% |
| SIGNATUREFD, LLC | 04/07/2026 | 23 | $66 | 0.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 05/05/2026 | 21 | $60 | 0.00% | 0.00% |
| NBC SECURITIES, INC. | 04/14/2026 | 20 | $57 | 0.00% | 0.00% |
| ADVISORNET FINANCIAL, INC | 04/17/2026 | 19 | $54 | 0.00% | 0.00% |
| SUNBELT SECURITIES, INC. | 05/18/2026 | 10 | $29 | 0.00% | 0.00% |
| INSPIRE INVESTING, LLC | 04/23/2026 | 9 | $25 | -10.00% | 0.00% |
| CWM, LLC | 05/14/2026 | 8 | $23 | 100.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 6 | $17 | 0.00% | 0.00% |
| TIDEMARK, LLC | 05/07/2026 | 2 | $6 | 0.00% | 0.00% |
| CITIGROUP INC | 05/11/2026 | 1 | $3 | -98.88% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Alaunos Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 97 institutional investors and hedge funds held shares of Alaunos Therapeutics Inc. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 22,560
BlackRock, Inc.: 21,353
VANGUARD FIDUCIARY TRUST CO: 15,497
HRT FINANCIAL LP: 13,327
TWO SIGMA INVESTMENTS, LP: 10,839
CITADEL ADVISORS LLC: 10,519
6.46% of Alaunos Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 13.83 M shares in the last 24 months. This purchase volume represents approximately $50.63 M in transactions.